By the time results arrive, the doctor may have moved on to another patient.
For decades, the terrifying wait during a suspected heart attack has been measured not just in minutes, but in uncertainty — a silence that stretches between a blood draw and a diagnosis that could change everything. Researchers backed by the British Heart Foundation have now compressed that two-hour window into twenty minutes, using a bedside cartridge device that reads troponin levels on the spot, without sending blood to a distant laboratory. A multi-hospital study found patients received care decisions nearly an hour faster, with no increase in missed diagnoses. In the architecture of emergency medicine, this is not merely a technical refinement — it is a reclaiming of time at its most human and consequential.
- Every year, thousands of patients sit in emergency departments for up to two hours not knowing whether their heart is failing — a wait that is both medically dangerous and psychologically devastating.
- The bottleneck is structural: blood leaves the bedside, travels to a lab, and results return only after the attending doctor has often moved on to another patient.
- A new point-of-care cartridge device places a single drop of blood into a bedside reader and delivers troponin results in twenty minutes, keeping doctor, patient, and answer in the same room at the same moment.
- Across six hospitals, patients tested with the rapid method received admission or discharge decisions forty-seven minutes faster on average — with no rise in missed heart attacks or thirty-day cardiovascular deaths.
- Some NHS hospitals are already deploying the technology, and researchers envision it spreading to GP practices and chest pain clinics, catching cardiac events far earlier in the care journey.
When someone arrives at an emergency department gripping their chest, two clocks start running at once — the clinical clock measuring tissue damage, and the human clock measuring fear. For decades, both have been governed by the same constraint: a blood test that takes up to two hours to return a result.
The test in question measures troponin, a protein that leaks into the bloodstream when heart muscle is damaged. It is reliable. But reliability has always come at the cost of time — blood drawn, sent to a laboratory elsewhere in the hospital, analysed, and returned, often after the doctor who ordered it has moved on to another patient. The person in the bed waits, frightened and uncertain, while treatment decisions are deferred.
Researchers backed by the British Heart Foundation have now changed that equation. A bedside cartridge device accepts a single drop of blood, analyses troponin levels on the spot, and delivers results in twenty minutes. The diagnosis happens in real time, in the room, while the clinical team is still present.
A study led by Christchurch Hospital in New Zealand, spanning six hospitals, found that patients using the rapid test received admission or discharge decisions forty-seven minutes faster on average than those awaiting traditional laboratory results. Critically, speed did not compromise safety — rates of cardiovascular death or heart attack within thirty days were identical across both groups.
Cardiology professor Nicholas Mills of the University of Edinburgh, who helped design the study, framed the stakes plainly: the anxiety of not knowing whether your heart has been damaged is itself a form of harm. The rapid test resolves that uncertainty while the doctor is still standing there.
The implications extend beyond individual relief. NHS emergency departments are chronically overstretched, and faster diagnostic decisions mean faster patient flow — quicker discharges for those who are safe to leave, quicker admissions for those who are not. Mills has also pointed to the technology's potential in GP surgeries and chest pain clinics, where patients experiencing cardiac symptoms might otherwise wait hours for a hospital referral to confirm what a bedside device could answer in twenty minutes.
The test is already in use in some British hospitals. What remains is the work of scaling — spreading the technology into primary care and into the earliest points of contact between patients and the health system. The tool exists. The question now is how quickly it reaches the people who need it.
When someone arrives at a hospital emergency department clutching their chest, afraid they might be having a heart attack, the clock starts ticking in two directions at once. Doctors need to know what's happening. The patient needs to know what's happening. But for the past several decades, that answer has taken up to two hours to arrive.
The delay happens because of how we've always diagnosed heart attacks. A nurse draws blood and sends it to a laboratory somewhere else in the hospital. Technicians there test for troponin, a protein that spills into the bloodstream when heart muscle is damaged. It's a reliable test. The problem is the waiting. By the time results come back, the doctor who ordered the blood work may have moved on to another patient. The person in the bed—frightened, in pain, uncertain—waits longer for treatment decisions that could be lifesaving.
Researchers backed by the British Heart Foundation have now developed a way to collapse that two-hour window into twenty minutes. The innovation is elegantly simple: instead of sending blood away for analysis, a technician places a single drop on a cartridge, inserts it into a bedside device, and the machine reads troponin levels on the spot. The diagnosis happens right there, in real time, while the patient is still in front of the doctor.
A study led by Christchurch Hospital in New Zealand tested this rapid approach across six hospitals and found something striking. Patients who received the quick test were admitted to a ward or sent home forty-seven minutes faster on average than those who waited for traditional laboratory results. That's not a marginal improvement. That's nearly an hour shaved off the decision-making process during what may be the most frightening moments of someone's life. And crucially, the faster test didn't miss heart attacks. The rate of people who died from cardiovascular causes or suffered a heart attack within thirty days of their emergency visit was the same whether they'd had the standard test or the rapid one. Speed didn't come at the cost of accuracy.
Some British hospitals have already begun using this technology. Nicholas Mills, a cardiology professor at the University of Edinburgh who helped design the study, explained the human dimension plainly: the anxiety of waiting for an answer about whether your heart has been damaged is itself a kind of injury. "When people go to the emergency department fearing they have had a heart attack, a blood sample is taken and sent to another part of the hospital for analysis," Mills said. "By the time the results are available, it is likely the doctor or nurse will have been called away." The rapid test changes that equation. Results arrive while the clinical team is still present, decisions get made, treatment begins.
Beyond the immediate relief for individual patients, the test addresses a systemic problem. Emergency departments across the NHS are chronically overcrowded. Faster diagnostic decisions mean faster patient flow. Someone who can be safely discharged leaves the department sooner. Someone who needs admission gets to a ward sooner. The bottleneck loosens. Mills noted that the technology could ease pressure on these overwhelmed departments, helping people move through more quickly.
The researchers also see potential beyond emergency rooms. The same cartridge-and-device approach could work in GP practices and chest pain clinics, catching heart attacks that might otherwise slip through undetected in settings where patients don't arrive by ambulance. A person experiencing chest pain in a doctor's office could get an answer in twenty minutes instead of being sent to hospital and waiting two hours.
The test is already in use. What comes next is scaling—expanding it into more hospitals, into primary care, into the places where people first seek help when something feels wrong with their heart. For now, the technology exists. The question is how quickly it spreads.
Notable Quotes
When people go to the emergency department fearing they have had a heart attack, a blood sample is taken and sent to another part of the hospital for analysis. By the time the results are available, it is likely the doctor or nurse will have been called away.— Nicholas Mills, BHF Professor of Cardiology at the University of Edinburgh
The Hearth Conversation Another angle on the story
Why does it matter that we've cut this from two hours to twenty minutes? Isn't a diagnosis a diagnosis?
The difference is what happens while you're waiting. If you think you're having a heart attack, those two hours are two hours of not knowing if you're going to die. And practically, your doctor might have left to see another patient by the time your results come back, so treatment gets delayed again.
So it's both psychological and practical.
Exactly. The anxiety is real and it matters. But also, in a true cardiac emergency, every minute counts for treatment. Faster diagnosis means faster intervention.
The study found no difference in missed diagnoses. That's the part that surprised me—that speed didn't sacrifice accuracy.
That's what makes this genuinely significant. You could imagine a faster test being less reliable. But this one maintains the same diagnostic standard while collapsing the timeline. It's not a trade-off.
What about the NHS angle? How does this help with overcrowding?
If you can discharge someone safely in thirty minutes instead of ninety, that bed opens up. That's one more person who can be admitted. It's a throughput problem, and this is a throughput solution.